Enalapril Worldwide Experience
作者： Richard O. Davies , John D. Irvin , Dieter K. Kramsch , J. Findlay Walker , Federico Moncloa
DOI: 10.1016/S0002-9343(84)80055-8
关键词:
摘要: … aldosteronism produced by hydrochlorothiazide. These … the attenuation of diuretic-induced hypokalemia by enalapril. … No case of neutropenia or agranulocytosis was encountered …
amjmed.com
elsevier.com
sci-hub.se 参考文章(18)
H C Wenger, C A Stone, A A Morris, D M Gross, E H Ulm, D Weitz, D L Bohn, E P Backlund, C S Sweet, T C Vassil, Effect of N-[(S)-1-carboxy-3-phenylpropyl]-L-Ala-L-Pro and its ethyl ester (MK-421) on angiotensin converting enzyme in vitro and angiotensin I pressor responses in vivo. Journal of Pharmacology and Experimental Therapeutics. ,vol. 216, pp. 552- 557 ,(1981)
Charles S. Sweet, Phyllis T. Arbegast, S. Lee Gaul, Edward H. Blaine, Dennis M. Gross, Relationship between angiotensin I blockade and antihypertensive properties of single doses of MK-421 and captopril in spontaneous and renal hypertensive rats. European Journal of Pharmacology. ,vol. 76, pp. 167- 176 ,(1981) , 10.1016/0014-2999(81)90498-2
J Biollaz, M Burnier, G A Turini, D B Brunner, M Porchet, H J Gomez, K H Jones, F Ferber, W B Abrams, H Gavras, H R Brunner, Three new long-acting converting-enzyme inhibitors: Relationship between plasma converting-enzyme activity and response to angiotensin I Clinical Pharmacology and Therapeutics. ,vol. 29, pp. 665- 670 ,(1981) , 10.1038/CLPT.1981.92
D.B. Brunner, G. Desponds, J. Biollaz, I. Keller, F. Ferber, H. Gavras, H.R. Brunner, J.L. Schelling, Effect of a new angiotensin converting enzyme inhibitor MK 421 and its lysine analogue on the components of the renin system in healthy subjects British Journal of Clinical Pharmacology. ,vol. 58, pp. S778- S784 ,(2004) , 10.1111/J.1365-2125.2004.02294.X
EH Ulm, M Hichens, HJ Gomez, AE Till, E Hand, TC Vassil, J Biollaz, HR Brunner, JL Schelling, Enalapril maleate and a lysine analogue (MK‐521): disposition in man. British Journal of Clinical Pharmacology. ,vol. 14, pp. 357- 362 ,(1982) , 10.1111/J.1365-2125.1982.TB01991.X
M.D. Cressman, D.G. Vidt, C. Acker, RENAL GLYCOSURIA AND AZOTAEMIA AFTER ENALAPRIL MALEATE (MK-421) The Lancet. ,vol. 320, pp. 440- ,(1982) , 10.1016/S0140-6736(82)90468-8
G A MacGregor, N D Markandu, J Bayliss, J E Roulston, M Squires, J J Morton, Non-sulfhydryl-containing angiotensin-converting enzyme inhibitor (MK421): evidence for role of renin system in normotensive subjects. BMJ. ,vol. 283, pp. 401- 403 ,(1981) , 10.1136/BMJ.283.6288.401
Roger K Ferguson, Peter H Vlasses, Brian N Swanson, Parviz Mojaverian, Martin Hichens, John D Irvin, Paul B Huber, Effects of enalapril, a new converting enzyme inhibitor, in hypertension. Clinical Pharmacology & Therapeutics. ,vol. 32, pp. 48- 53 ,(1982) , 10.1038/CLPT.1982.125
Haralambos Gavras, Bernard Waeber, Irene Gavras, Jerome Biollaz, HansR. Brunner, RichardO. Davies, ANTIHYPERTENSIVE EFFECT OF THE NEW ORAL ANGIOTENSIN CONVERTING ENZYME INHIBITOR "MK-421". The Lancet. ,vol. 318, pp. 543- 547 ,(1981) , 10.1016/S0140-6736(81)90937-5
P H Vlasses, H H Rotmensch, R K Ferguson, S L Sheaffer, "Scalded mouth" caused by angiotensin-converting-enzyme inhibitors. BMJ. ,vol. 284, pp. 1672- 1673 ,(1982) , 10.1136/BMJ.284.6330.1672